| P50 | author | Noton Kumar Dutta | Q46213104 |
| P2093 | author name string | Deepak Kaushal | |
| | Smriti Mehra | |
| P2860 | cites work | Antitubercular activity of trifluoperazine, a calmodulin antagonist | Q28317206 |
| | An integrated regulatory network including two positive feedback loops to modulate the activity of sigma(E) in mycobacteria. | Q54702615 |
| | Mycobacterium tuberculosis Invasion of Macrophages: Linking Bacterial Gene Expression to Environmental Cues | Q60343829 |
| | Synthesis and antitubercular activity of quaternized promazine and promethazine derivatives | Q63363593 |
| | The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis | Q73821527 |
| | Sigma factors of Mycobacterium tuberculosis | Q77130702 |
| | Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates | Q77823582 |
| | Evidence for complex interactions of stress-associated regulons in an mprAB deletion mutant of Mycobacterium tuberculosis | Q80019159 |
| | Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration | Q43112687 |
| | The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015. | Q43186490 |
| | RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine | Q43190151 |
| | Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacterium tuberculosis in mice. | Q43288621 |
| | Metabolic engineering through cofactor manipulation and its effects on metabolic flux redistribution in Escherichia coli | Q43992582 |
| | The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. | Q44944734 |
| | Global transcriptional response to vancomycin in Mycobacterium tuberculosis. | Q45977495 |
| | Reversal of methicillin resistance in Staphylococcus aureus by thioridazine | Q46331077 |
| | Steady-state kinetics and inhibitory action of antitubercular phenothiazines on mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2). | Q46937313 |
| | The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action | Q47215316 |
| | The extracytoplasmic function sigma factors: role and regulation | Q47782717 |
| | Characterization of RNA polymerase and two sigma-factor genes from Mycobacterium smegmatis | Q48076343 |
| | Role of the extracytoplasmic-function sigma factor sigma(H) in Mycobacterium tuberculosis global gene expression | Q28486621 |
| | The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages | Q28486647 |
| | RseA, the SigE specific anti-sigma factor of Mycobacterium tuberculosis, is inactivated by phosphorylation-dependent ClpC1P2 proteolysis | Q28486942 |
| | Secreted transcription factor controls Mycobacterium tuberculosis virulence | Q28487057 |
| | Functional genomics reveals extended roles of the Mycobacterium tuberculosis stress response factor sigmaH | Q28487106 |
| | Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs | Q28487121 |
| | Differential expression of sigE by Mycobacterium tuberculosis during intracellular growth | Q28487158 |
| | A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in Mycobacterium tuberculosis | Q28487314 |
| | Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment | Q28487339 |
| | Construction and characterization of a Mycobacterium tuberculosis mutant lacking the alternate sigma factor gene, sigF. | Q28487440 |
| | Roles of SigB and SigF in the Mycobacterium tuberculosis sigma factor network | Q28487509 |
| | Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis | Q28487562 |
| | Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs. | Q33855579 |
| | Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method. | Q34001917 |
| | Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: modulation of gp63 level in promastigotes and their infection of macrophages in vitro | Q34002959 |
| | Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH | Q34032570 |
| | Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates | Q34123800 |
| | Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice | Q34654673 |
| | Deletion of Mycobacterium tuberculosis sigma factor E results in delayed time to death with bacterial persistence in the lungs of aerosol-infected mice | Q34944794 |
| | Sigma factors and global gene regulation in Mycobacterium tuberculosis | Q35648489 |
| | Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS) | Q35656072 |
| | The sigma 70 family: sequence conservation and evolutionary relationships | Q36112378 |
| | Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization | Q36558993 |
| | Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps | Q36705837 |
| | Reversal of resistance in microorganisms by help of non-antibiotics | Q36778267 |
| | Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis | Q37031891 |
| | Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities | Q37052368 |
| | Promising therapy of XDR-TB/MDR-TB with thioridazine an inhibitor of bacterial efflux pumps. | Q37264683 |
| | The curative activity of thioridazine on mice infected with Mycobacterium tuberculosis. | Q39220003 |
| | In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis | Q39220012 |
| | Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis | Q39326462 |
| | Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines | Q39563408 |
| | The Mycobacterium tuberculosis TrcR response regulator represses transcription of the intracellularly expressed Rv1057 gene, encoding a seven-bladed beta-propeller. | Q40723997 |
| | Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis | Q40968122 |
| | The Mycobacterium tuberculosis sigma factor sigmaB is required for full response to cell envelope stress and hypoxia in vitro, but it is dispensable for in vivo growth | Q42545993 |
| | In-vitro and intracellular antimycobacterial activity of trifluoperazine | Q42556172 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | e10069 | |
| P577 | publication date | 2010-04-08 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine | |
| P478 | volume | 5 | |